Annovis Bio, Inc. (ANVS) — Total Assets
| Fiscal Year | Total Assets | Change YoY |
|---|---|---|
| 2025 | $21.08M | +51.4% |
| 2024 | $13.93M | +36.4% |
| 2023 | $10.21M | -71.7% |
| 2022 | $36.02M | -21.7% |
| 2021 | $46.00M | +466.6% |
| 2020 | $8.12M | +626.8% |
| 2019 | $1.12M | — |
| Fiscal Year | Total Assets | Change YoY |
|---|---|---|
| 2025 | $21.08M | +51.4% |
| 2024 | $13.93M | +36.4% |
| 2023 | $10.21M | -71.7% |
| 2022 | $36.02M | -21.7% |
| 2021 | $46.00M | +466.6% |
| 2020 | $8.12M | +626.8% |
| 2019 | $1.12M | — |